Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?

Brooimans, RA; van der Velden, VHJ; Boeckx, N; Slomp, J; Preijers, F; te Marvelde, JG; Van, NM; Heijs, A; Huys, E; van der Holt, B; de Greef, GE; Kelder, A; Schuurhuis, GJ

Brooimans, RA (reprint author), Univ Med Ctr Rotterdam, Erasmus MC, Lab Med Immunol, Dept Immunol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.

LEUKEMIA RESEARCH, 2019; 76 (): 39

Abstract

Flow-cytometric detection of now termed measurable residual disease (MRD) in acute myeloid leukemia (AML) has proven to have an independent prognostic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索